natgillin/translations-raw huggingface dataset:
Ob tem je KOREU najobsežnejši sporazum o prosti trgovini, ki ga je izpogajala EU, in vodilna strategija o globalni Evropi ter vključuje odstranitev visokih tarif, odpravo netarifnih ovir za trgovino, boljši dostop do trga blaga in storitev, priznavanje mednarodnih in evropskih standardov, zaščito geografskih oznak ter zavezo k trajnostnem razvoju.
Furthermore, the KOREU is the most comprehensive FTA ever negotiated by the EU and the flagship of the Global Europe Strategy, including dismantling of high tariffs, the elimination of Non-tariff barriers to trade, better market access for goods and services, recognition of international and European standards, protection of geographical indications, as well as commitments for sustainable development.
Ob tem so številne študije pokazale bistvene koristi za evropsko in tudi korejsko gospodarstvo:
Moreover, several studies concluded to crucial benefits for both the European and Korean economies:
- BDP Evropske unije in Koreje se bo bistveno povišal;
- GDP within the EU and in Korea will rise significantly;
- izvoz EU v Korejo se bo povišal za 82,6 %, korejski izvoz v EU pa bo zaradi odprave tarifnih in netarifnih ovir višji za 38,4 %;
- EU exports to Korea will rise up to 82,6% and Korean exports up to 38,4% to the EU due to the elimination of tariffs and Non Tariff Barriers;
- izvozniki industrijskega in kmetijskega blaga v Korejo bodo oproščeni dajatev v višini do 1,6 milijarde evrov letno;
- exporters of industrial and agricultural goods to Korea will be relieved from duties up to € 1.6 billion per year;
- razvilo se bo znatno novo trgovanje z blagom in storitvami, kar bo za EU ustvarilo 19,1 milijarde evrov.
- substantial new trade in goods and services will be created up to 19.1 billion for the EU,
Poročevalec priznava, da je Komisija v celoti upoštevala pogajalska priporočila, ki jih je leta 2008 izrazil Evropski parlament v poročilu Odbora INTA o Koreji.
The Rapporteur acknowledges that the Commission took the negotiation recommendations expressed by the European Parliament in the INTA Korea Report from 2008 fully into account.
Poleg tega je Evropski parlament v celoti upošteval tudi izjave številnih evropskih poslovnih organizacij, industrij, družb in sindikatov.
On its side, the EP took statements by many European business organizations, industries, companies and trade unions fully into account.
Predstavniki civilne družbe so bili udeleženi v celotnem postopku pogajanj o sporazumu o prosti trgovini EU-Koreja, na primer prek dialoga na sestankih s predstavniki civilne družbe in v postopku posvetovanja, ki je vodil k pripravi ocene trgovinskega trajnostnega učinka sporazuma o prosti trgovini EU-Koreja.
The civil society representatives were involved throughout the process of negotiations of the EU-Korea FTA for example via the civil society dialogue meetings and the consultation process that led to preparation of the Trade Sustainability Impact Assessment of the EU-Korea FTA.
Sporazum o prosti trgovini vzpostavlja tudi institucionalne strukture za izvajanje in spremljanje zavez med stranmi, vključno z udeležbo civilne družbe.
The FTA even sets up institutional structures to implement and monitor the commitments between the parties, including through civil society involvement.
Vsaka od strani bo imenovala svetovalno skupino predstavnikov civilne družbe (imenovano nacionalna svetovalna skupina), ki bo uravnoteženo predstavljala okoljske, delavske in poslovne organizacije.
Each side will set up a civil society advisory group (so called Domestic Advisory Group), including a balanced representation of environment, labour and business organisations.
Na koncu je poročevalec spomnil na resno zaskrbljenost, ki so jo izrazili nekateri predstavniki evropske industrije, zlasti tisti iz avtomobilskega sektorja, ki pa jih bo, po njegovem mnenju, v okviru zaščitnih ukrepov obravnaval Evropski parlament.
Finally, the Rapporteur took note of the serious concerns expressed by some European industries, especially in the automotive sector which, in his opinion, will be addressed by the European Parliament within the safeguard regulation.
Ta dvostranska zaščitna klavzula predvideva ponovno uvedbo stopnje za državo z največjimi ugodnostmi, kadar se, kot rezultat liberalizacije trgovine, uvoz poveča v tolikšnem obsegu – v absolutnem smislu ali glede na domačo proizvodnjo – in pod takšnimi pogoji, da povzroča resno škodo ali resno ogroža industrijo Unije, ki proizvaja podoben ali neposredno konkurenčen izdelek.
This bilateral safeguard clause provides for the possibility of reimposing the most-favoured-nation (MFN) rate when, as a result of trade liberalisation, imports increase to such an extent – in absolute terms or in relation to domestic production – and take place under such conditions as to cause, or threaten to cause, serious injury to the EU industry producing a similar or directly competing product.
Odbor za industrijo, raziskave in energetiko poziva Odbor za mednarodno trgovino kot pristojni odbor, naj Parlamentu predlaga odobritev sporazuma.
The Committee on Industry, Research and Energy calls on the Committee on International Trade, as the committee responsible, to propose that Parliament give its consent.
Jean-Pierre Audy, Ivo Belet, Bendt Bendtsen, Jan Březina, Maria Da Graça Carvalho, Giles Chichester, Pilar del Castillo Vera, Lena Ek, Ioan Enciu, Gaston Franco, Adam Gierek, Norbert Glante, Jacky Hénin, Edit Herczog, Romana Jordan Cizelj, Arturs Krišjānis Kariņš, Lena Kolarska-Bobińska, Bogdan Kazimierz Marcinkiewicz, Angelika Niebler, Jaroslav Paška, Ani Podimata (Anni Podimata), Miloslav Ransdorf, Herbert Reul, Teresa Riera Madurell, Jens Rohde, Paul Rübig, Amalia Sartori, Francisco Sosa Wagner, Konrad Szymański, Britta Thomsen, Patrizia Toia, Evžen Tošenovský, Claude Turmes, Niki Cavela (Niki Tzavela), Marita Ulvskog, Vladimir Uručev (Vladimir Urutchev), Adina-Ioana Vălean, Kathleen Van Brempt, Alejo Vidal-Quadras
Jean-Pierre Audy, Ivo Belet, Bendt Bendtsen, Jan Březina, Maria Da Graça Carvalho, Giles Chichester, Pilar del Castillo Vera, Lena Ek, Ioan Enciu, Gaston Franco, Adam Gierek, Norbert Glante, Jacky Hénin, Edit Herczog, Romana Jordan Cizelj, Arturs Krišjānis Kariņš, Lena Kolarska-Bobińska, Bogdan Kazimierz Marcinkiewicz, Angelika Niebler, Jaroslav Paška, Anni Podimata, Miloslav Ransdorf, Herbert Reul, Teresa Riera Madurell, Jens Rohde, Paul Rübig, Amalia Sartori, Francisco Sosa Wagner, Konrad Szymański, Britta Thomsen, Patrizia Toia, Evžen Tošenovský, Claude Turmes, Niki Tzavela, Marita Ulvskog, Vladimir Urutchev, Adina-Ioana Vălean, Kathleen Van Brempt, Alejo Vidal-Quadras
William (grof) Dartmouthski, David Campbell Bannerman, Daniel Caspary, Marielle De Sarnez, Christofer Fjellner, Yannick Jadot, Metin Kazak, Emilio Menéndez del Valle, Vital Moreira, Godelieve Quisthoudt-Rowohl, Tokia Saïfi, Helmut Scholz, Robert Sturdy, Gianluca Susta, Keith Taylor, Iuliu Winkler, Pablo Zalba Bidegain
William (The Earl of) Dartmouth, David Campbell Bannerman, Daniel Caspary, Marielle De Sarnez, Christofer Fjellner, Yannick Jadot, Metin Kazak, Emilio Menéndez del Valle, Vital Moreira, Godelieve Quisthoudt-Rowohl, Tokia Saïfi, Helmut Scholz, Robert Sturdy, Gianluca Susta, Keith Taylor, Iuliu Winkler, Pablo Zalba Bidegain
o oceni ukrepov za obvladovanje gripe H1N1 v letih 2009 in 2010 v EU
on evaluation of the management of H1N1 influenza in 2009-2010 in the EU
Poročevalka: Michèle Rivasi
Rapporteur: Michèle Rivasi
– ob upoštevanju člena 168 Pogodbe o delovanju Evropske unije,
– having regard to Article 168 of the Treaty of the Functioning of the European Union,
– ob upoštevanju mednarodnega zdravstvenega pravilnika – IHR(2005)
– having regard to the International Health Regulations – IHR (2005) 2005
– ob upoštevanju Sporočila Komisije z dne 28. novembra 2005 o načrtovanju pripravljenosti in odziva na pandemijo influence v Evropski skupnosti ( KOM(2005)0607 ),
– having regard to the Commission communication of 28 November 2005 on pandemic influenza preparedness and response planning in the European Community ( COM(2005)0607 ),
– ob upoštevanju delovnega dokumenta Sveta z dne 30. novembra 2007 vprašanjih, povezanih z varovanjem zdravja
– having regard to the Council working document of 30 November 2007 on health security related matters
– ob upoštevanju sklepov Sveta o varovanju zdravja z dne 16. decembra 2008
– having regard to the Council Conclusions of 16 December 2008 on health security
– ob upoštevanju dokumenta o začasnih smernicah o uporabi posebnih cepiv za pandemično gripo med pandemijo H1N1 2009
– having regard to the ECDC interim guidance document on ‘Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic’
– ob upoštevanju napotkov Svetovne zdravstvene organizacije iz aprila 2009 o pripravljenosti in odzivu na pandemično influenco
– having regard to the WHO guidance document of April 2009 on pandemic influenza preparedness and response
– ob upoštevanju Sklepov Sveta z dne 30. aprila 2009
– having regard to the Council Conclusions of 30 April 2009
http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/lsa/107492.pdf . o gripi A/okužbi z H1N1,
http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/lsa/107492.pdf on Influenza A/H1N1 infection,
– ob upoštevanju izmenjave mnenj med direktorico Evropskega centra za preprečevanje in nadzor bolezni in svojega Odbora za okolje, javno zdravje in varno hrano, ki je potekalo 4. septembra 2009,
– having regard to the exchange of views between the ECDC director and Parliament’s Committee on the Environment, Public Health and Food Safety, which took place on 4 September 2009,
– ob upoštevanju sporočila Komisije z dne 15. septembra 2009 o pandemiji (H1N1) 2009
– having regard to the Commission communication of 15 September 2009 on Pandemic (H1N1) 2009
– ob upoštevanju delovnega dokumenta Komisije z dne 15. septembra 2009 o skupnem naročilu cepiva proti gripi A (H1N1)
– having regard to the Commission Staff Working Document of 15 September 2009 on Joint procurement of vaccine against influenza A (H1N1)
– ob upoštevanju delovnega dokumenta Komisije z dne 15. septembra 2009 o komuniciranju z javnostjo in mediji o pandemiji (H1N1) 2009
– having regard to the Commission Staff Working Document of 15 September 2009 on communicating with the public and the media on Pandemic (H1N1) 2009
– ob upoštevanju delovnega dokumenta Komisije z dne 15. septembra 2009 o pomoči tretjim državam pri boju proti gripi A (H1N1)
– having regard to the Commission Staff Working Document of 15 September 2009 on support to third countries to fight the Influenza A (H1N1)
– ob upoštevanju delovnega dokumenta Komisije z dne 15. septembra 2009 o regulativnem postopku za odobritev antivirusnih zdravil in cepiv za zaščito pred pandemično gripo (H1N1) 2009
– having regard to the Commission Staff Working Document of 15 September 2009 on the regulatory process for the authorisation of antiviral medicines and vaccines in the protection against Pandemic Influenza (H1N1) 2009
– ob upoštevanju delovnega dokumenta Komisije z dne 15. septembra 2009 o strategijah cepljenja proti pandemiji (H1N1) 2009
– having regard to the Commission Staff Working Document of 15 September 2009 on vaccination strategies against pandemic (H1N1) 2009
http://ec.europa.eu/health/communicable_diseases/diseases/influenza/h1n1/index_en.htm#fragment2 in
http://ec.europa.eu/health/communicable_diseases/diseases/influenza/h1n1/index_en.htm#fragment2 and
– ob upoštevanju dokumenta z naslovom Evropske strategije za gripo A/H1N1 – spremljanje koristi in tveganja cepljenja, oktober 2009
– having regard to the document entitled ‘ European Strategy for Influenza A/H1N1 – Vaccine Benefit-Risk Monitoring’ of October 2009
– ob upoštevanju sklepov Sveta z dne 12. oktobra 2009 o pandemiji (H1N1) 2009 – strateški pristop
– having regard to the Council Conclusions of 12 October 2009 on the Pandemic (H1N1) 2009 – a strategic approach
– ob upoštevanju delovnega dokumenta Komisije z dne 23. novembra 2009 o varovanju zdravja v Evropski uniji in na mednarodni ravni
– having regard to the Commission Staff Working Document of 23 November 2009 on Health Security in the European Union and Internationally
– ob upoštevanju ocenjevalnega poročila z dne 16. aprila 2010 o odzivu celotne EU na pandemijo H1N1 2009
– having regard to the Assessment Report of 16 April 2010 on EU‑Wide Response to the Pandemic (H1N1) 2009
– ob upoštevanju končnega poročila iz januarja 2010 o oceni Evropske agencije za zdravila
– having regard to the final report of January 2010 on the Evaluation of the European Medicines Agency
– ob upoštevanju resolucije 1749 (2010) z naslovom Obvladovanje pandemije gripe H1N1: potreba po večji preglednosti, ki jo je junija 2010 sprejela parlamentarna skupščina Sveta Evrope
– having regard to Resolution 1749 (2010) ‘Handling of the H1N1 pandemic: more transparency needed’ adopted by the Parliamentary Assembly of the Council of Europe in June 2010
– ob upoštevanju sklepov konference ali naukov iz pandemije gripe A (H1N1), ki je potekala 1. in 2. julija 2010
– having regard to the conclusions of the Conference on lessons learned from the A (H1N1) pandemic, held on 1 and 2 July 2010
– ob upoštevanju priporočil Evropskega varuha človekovih pravic o Evropski agenciji za zdravila z dne 29. aprila in 19. maja 2010
– having regard to the recommendations of the European Ombudsman concerning the European Medicines Agency of 29 April and 19 May 2010
http://www.ombudsman.europa.eu/press/release.faces/fr/4940/html.bookmark in
http://www.ombudsman.europa.eu/press/release.faces/fr/4940/html.bookmark and
– ob upoštevanju poročila z dne 25. avgusta 2010 o oceni strategij za cepiva proti pandemični gripi v celotni EU
– having regard to the Assessment Report of 25 August 2010 on EU‑Wide Pandemic Vaccine Strategies
– ob upoštevanju sklepov Sveta z dne 13. septembra 2010 o izkušnjah, pridobljenih s pandemijo gripe A (H1N1) – zdravstveno varstvo v EU
– having regard to the Council Conclusions of 13 September 2010 on Lessons learned from the A/H1N1 pandemic – Health security in the EU
– ob upoštevanju delovnega dokumenta osebja Komisije z dne 18. novembra 2010
– having regard to the Commission Staff Working Document of 18 November 2010
SEC (2010) 1440 končno,
SEC (2010) 1440 final,
http://ec.europa.eu/health/preparedness_response/docs/commission_staff_lessonsh1n1_en.pdf . o izkušnjah, pridobljenih s pandemijo gripe H1N1, in o zdravstvenem varstvu v Evropski uniji,
http://ec.europa.eu/health/preparedness_response/docs/commission_staff_lessonsh1n1_en.pdf on lessons learnt from the H1N1 pandemic and on health security in the European Union,
– ob upoštevanju letnega epidemiološkega poročila o nalezljivih boleznih v Evropi 2010, ki ga je objavil Evropski center za preprečevanje in nadzor bolezni
- having regard to the Annual epidemiological report on communicable diseases in Europe 2010 by the ECDC
– ob upoštevanju poročila Odbora za okolje, javno zdravje in varnost hrane ( A7-0035/2011 ),
– having regard to the report of the Committee on the Environment, Public Health and Food Safety ( A7-0035/2011 ),
– ob upoštevanju delavnice Odbora Evropskega parlamenta za okolje, javno zdravje in varnost hrane o pandemiji gripe A (H1N1) – odziv držav članic in Evropske unije, ki je potekala 5. oktobra 2010,
- having regard to the Workshop held on 5 October 2010 by the European Parliament’s Committee on the Environment, Public Health and Food Safety on the Influenza Pandemic A (H1N1) - The response of Member States and the European Union,
A. ker so nacionalni in mednarodni zdravstveni organi, tudi Svetovna zdravstvena organizacija, maja 2009 izjavili, da je v tistem obdobju gripa H1N1 povzročala le lažja obolenja, vendar ni samoumevno, da se bo ta vzorec nadaljeval,
A. whereas the national and international health authorities, including the WHO, stated in May 2009 that the H1N1 influenza was at the time causing only mild illness, but that it could not be taken for granted that this pattern would continue,
B. ker so v skladu z mednarodnim zdravstvenim pravilnikom, ki je pravno zavezujoč instrument za države podpisnice, naloge Svetovne zdravstvene organizacije med drugim nadzor javnega zdravja, usklajevanje mednarodnih dejavnosti na tem področju in razglasitev faze virusa, ki bi lahko bil pandemičen, na podlagi 6-stopenjske lestvice,
B. whereas, under the International Health Regulations (IHR) – a legal instrument binding on the states parties to it – the remit of the WHO includes public health surveillance, coordinating international public health measures and, in relation to potentially pandemic viruses, determining current phases of alert on a scale of one to six,
C. ker se faza svetovne pandemije razglasi na podlagi določb mednarodnega zdravstvenega pravilnika in v posvetovanju z drugimi organizacijami, institucijami in prizadetimi državami članicami,
C. whereas the phases of a global pandemic are determined in accordance with the provisions of the IHR and in consultation with other organisations and institutions and with the Member States affected,
D. ker merila o opredelitvi pandemije, ki jih je Svetovna zdravstvena organizacija leta 2009 ponovno pregledala, temeljijo zgolj na širjenju virusa in ne upoštevajo resnosti obolenja, ki ga ta povzroča,
D. whereas the criteria for defining a ‘pandemic’, as revised by the WHO in 2009, are based solely on the spread of the virus while disregarding the severity of the illness caused by it,
E. ker bi morale države članice, Evropska komisija in zunanji organi, na primer Svetovna zdravstvena organizacija, pri sprejemanju odločitev v javnem zdravstvu, ki bi lahko vplivale na javno zdravje in socialno politiko v državah članicah, upoštevati virulenco izbruha gripe v prihodnosti, pa tudi širjenje virusa,
E. whereas Member States, the European Commission and external bodies such as the WHO should take into account the virulence of a future influenza outbreak as well as the propagation of the virus when making public health decisions which may affect public health and social policies in Member States,
F. ker je stopnja nepredvidljivosti glede resnosti pandemije in njenega poteka visoka ter vedno obstaja možnost, da bi se lahko v Evropi zaostrila, kot se je leta 1918 in 1968,
F. considering the high degree of unforeseeability regarding the pandemic’s severity and how it was going to unfold, and the possibility that the pandemic might worsen in Europe, as it did in 1918 and 1968;
G. ker so se države članice na podlagi razglasitve pandemije Svetovne zdravstvene organizacije in priporočil, ki so temu sledila, v skladu z načelom previdnosti hitro odzvale glede na razpoložljiva sredstva, da bi vzpostavile zdravstvene akcijske načrte; ker so bile ob razglasitvi najvišje stopnje nevarnosti pandemije na področju javnega zdravja ponekod sprejete nesorazmerne odločitve;
G. whereas, on the basis of the WHO pandemic alert and subsequent recommendations, the Member States responded rapidly, in line with the precautionary principle, using what resources they had available to implement public health action plans; whereas the move to the highest level of alert, indicating the presence of a pandemic, gave rise in some cases to public health decisions that were disproportionate,
H. ker je Svetovna zdravstvena organizacija šele avgusta 2010 razglasila prenehanje stanja pripravljenosti na pandemijo gripe H1N1 (izjava generalnega direktorja Svetovne zdravstvene organizacije z dne 10. avgusta 2010
H. whereas the WHO called an end to the state of alert concerning H1N1 influenza only in August 2010 (statement by the WHO Director-General of 10 August 2010
I. ker v skladu z načelom subsidiarnosti priprava na zdravstvena tveganja v Evropski uniji in odziv nanj spada v pristojnost držav članic; ker Lizbonska pogodba poziva države članice, naj okrepijo sodelovanje, izmenjavo informacij in primerov dobre prakse v okviru Svetovne zdravstvene organizacije in obstoječih struktur EU; ker okrepljeni ukrepi Komisije za usklajevanje skupaj s podporo Evropskega centra za preprečevanje in nadzor bolezni ter Agencije za vrednotenje zdravil v okviru mednarodnega zdravstvenega pravilnika izboljšujejo učinkovitost nacionalnih ukrepov,
I. whereas, in accordance with the principle of subsidiarity, the preparation for and reaction to health risks in the European Union fall within the competence of the Member States; whereas the Treaty of Lisbon exhorts the Member States to strengthen cooperation, sharing of information and good practices within the framework of the WHO and the existing structures of the EU; whereas stronger coordination measures by the Commission,with the support of the ECDC and the EMEA within the framework of the International Health Regulation, reinforce the effectiveness of national measures,
J. ker se je morala farmacevtska industrija odzvati na nenadne, nujne in eksponentno naraščajoče zahteve držav članic glede dobave cepiv; ker je morala industrija zelo hitro razviti novo učinkovito cepivo proti virusu,
J. whereas the pharmaceutical industry had to respond to a sudden, pressing and exponential demand for the supply of vaccines by the Member States; whereas the industry had to develop with very great urgency a new vaccine likely to be effective against the virus,
K. ker so bili stroški upravljanja te krize v državah članicah visoki in bi jih morda lahko zmanjšali, če bi države članice sodelovale med seboj pa tudi z Evropskim centrom za preprečevanje in nadzor bolezni,
K. whereas the costs arising from the management of this crisis in the Member States were significant and could perhaps have been reduced by better cooperation between the Member States and better coordination between the Member States and ECDC,
L. ker je bil nakup velikih količin cepiv in protivirusnih zdravil glavni del stroškov, ki so jih imele nekatere države članice v okviru odziva na krizo, nabavni postopki pa so zbudili resne pomisleke glede spoštovanja pravil o javnih naročilih in preglednosti v nekaterih državah članicah,
L. whereas the expenditure committed by certain Member States to the response plans drawn up relates mainly to the purchase of vast quantities of vaccines and antiviral treatments, and whereas purchasing procedures led to concerns regarding compliance with rules on public procurement and transparency in some Member States,
M. ker so bile znatne cenovne razlike med državami članicami, ki so imele predhodne dogovore za nakup cepiva, med drugim zaradi diferenciranih pogojev glede odgovornosti v vsakem dogovoru,
M. whereas there were significant price disparities among the Member States that had prior purchase agreements for vaccines, based, among other factors, on the differentiated liability conditions of each agreement.
N. ker so bile v posameznih državah članicah na sodišče vložene pritožbe zaradi korupcije in zarote državnih uradnikov po tem, ko so poleti 2009 ministrstva za zdravje sklenila pogodbe s proizvajalci cepiv proti gripi H1N1,
N. whereas lawsuits were taken in various Member States, alleging corruption and conspiracy on the part of civil servants in relation to contracts signed in summer 2009 between ministries of public health and manufacturers of H1N1 influenza vaccines,
O. ker po poročanjih Komisije dobavitelji cepiv ne želijo nositi vso odgovornost za cepiva, kar je morda prispevalo k manjšem zaupanju državljanov v varnost cepiv; ker je zaupanje v cepiva proti gripi H1N1 postalo vprašljivo tudi zaradi pomanjkljivega in neskladnega obveščanja javnosti o koristih in tveganjih cepljenja ter morebitnih tveganjih pandemije gripe,
O. whereas, according to the Commission the reluctance of vaccine suppliers to bear full product liability may have contributed to reducing citizens’ trust in vaccine safety; whereas confidence in vaccines against H1N1 influenza was also undermined by incomplete and contradictory communication on the benefits and risks of vaccination and the potential risks of H1N1 influenza to the public,